Says submitted 510(k) application for next generation multiport platform da Vinci 5. Says da Vinci 5 will join existing robotic surgery portfolio. Says completed IDE trial on da Vinci 5. Says has been in contact with FDA and responding to questions regarding da Vinci five. Says initiated conversations about da 5 with regulators in Japan and Korea. Comments taken from Q4 earnings conference call.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ISRG:
- Intuitive Announces Fourth Quarter Earnings
- Options Volatility and Implied Earnings Moves Today, January 23, 2024
- Options Volatility and Implied Earnings Moves This Week, January 22 – January 26, 2024
- ISRG Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Intuitive Surgical price target raised to $392 from $340 at BTIG
